Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Invited commentary: uterine leiomyomata-we know so little but could learn so much.

Baird DD.

Am J Epidemiol. 2004 Jan 15;159(2):124-6. No abstract available.

PMID:
14718212
2.

Uterine leiomyomata--aetiology, symptomatology and management.

Buttram VC Jr.

Prog Clin Biol Res. 1986;225:275-96. Review. No abstract available.

PMID:
3538059
3.

Introduction: the epidemiology of uterine leiomyomas.

Vollenhoven B.

Baillieres Clin Obstet Gynaecol. 1998 Jun;12(2):169-76. Review.

PMID:
10023416
4.

Epidemiology of Uterine Fibroids: From Menarche to Menopause.

Wise LA, Laughlin-Tommaso SK.

Clin Obstet Gynecol. 2016 Mar;59(1):2-24. doi: 10.1097/GRF.0000000000000164. Review.

5.

Epidemiologic contributions to understanding the etiology of uterine leiomyomata.

Schwartz SM, Marshall LM, Baird DD.

Environ Health Perspect. 2000 Oct;108 Suppl 5:821-7. Review.

PMID:
11035989
6.

[Relation between progesterone and pathogenesis of uterine leiomyomas].

Yang Y, Zheng S.

Zhonghua Fu Chan Ke Za Zhi. 1996 Mar;31(3):184-5. Review. Chinese. No abstract available.

PMID:
8758794
7.

The need for gynaecological services during adolescence.

Widholm O.

Ann Chir Gynaecol Fenn. 1971;60(2):67-70. Review. No abstract available.

PMID:
4934543
8.

[Epidemiology of uterine fibroma: risk factors and frequency. Impact on public health].

Rongières C.

J Gynecol Obstet Biol Reprod (Paris). 1999 Nov;28(7):701-6. Review. French. No abstract available.

9.

Uterine artery embolization: a minimally invasive option to end fibroid symptoms.

Hiller JY, Miller MJ, Stavas JM.

Adv Nurse Pract. 2005 Oct;13(10):20-5; quiz 26. Review. No abstract available.

PMID:
16231549
10.

Etiology, symptomatology, and diagnosis of uterine myomas.

Parker WH.

Fertil Steril. 2007 Apr;87(4):725-36. Review.

PMID:
17430732
11.

Fibroids (uterine myomatosis, leiomyomas).

Lethaby A, Vollenhoven B.

Am Fam Physician. 2005 May 1;71(9):1753-6. Review. No abstract available.

12.

Uterine fibroids: the elephant in the room.

Walker CL, Stewart EA.

Science. 2005 Jun 10;308(5728):1589-92. Review.

PMID:
15947177
13.

Incidence, aetiology and epidemiology of uterine fibroids.

Okolo S.

Best Pract Res Clin Obstet Gynaecol. 2008 Aug;22(4):571-88. doi: 10.1016/j.bpobgyn.2008.04.002. Epub 2008 Jun 4. Review.

PMID:
18534913
14.

Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.

Hodge JC, Morton CC.

Hum Mol Genet. 2007 Apr 15;16 Spec No 1:R7-13. Review.

PMID:
17613550
15.

Endoscopic management of leiomyomata.

Advincula AP, Song A.

Semin Reprod Med. 2004 May;22(2):149-55. Review.

PMID:
15164310
16.

Modern management of uterine fibroids.

Levy BS.

Acta Obstet Gynecol Scand. 2008;87(8):812-23. doi: 10.1080/00016340802146912. Review.

PMID:
18607823
17.

Systematic review of mifepristone for the treatment of uterine leiomyomata.

Steinauer J, Pritts EA, Jackson R, Jacoby AF.

Obstet Gynecol. 2004 Jun;103(6):1331-6. Review.

PMID:
15172874
18.

Epidemiology, presentation, and management of retroperitoneal leiomyomata: systematic literature review and case report.

Poliquin V, Victory R, Vilos GA.

J Minim Invasive Gynecol. 2008 Mar-Apr;15(2):152-60. doi: 10.1016/j.jmig.2007.12.009. Review.

PMID:
18312983
19.

Gene expression studies in leiomyomata: new directions for research.

Catherino W, Salama A, Potlog-Nahari C, Leppert P, Tsibris J, Segars J.

Semin Reprod Med. 2004 May;22(2):83-90. Review.

PMID:
15164303
20.

Uterine artery embolization as a treatment option for uterine myomas.

Marshburn PB, Matthews ML, Hurst BS.

Obstet Gynecol Clin North Am. 2006 Mar;33(1):125-44. Review.

PMID:
16504811

Supplemental Content

Support Center